SELL TO SCIENTISTS.

Industry Profile

Antibody Discovery and Engineering

Target researchers — Immunologists and protein engineers with expertise in phage and yeast display, single B-cell sorting, humanization, bispecific antibody construction, Fc engineering, and affinity maturation

Antibody discovery platforms generate therapeutic, diagnostic, and research-grade antibodies through display technologies, single B-cell sorting, and computational design. The industry heavily licenses phage display libraries and B-cell discovery workflows from university immunology groups, recruiting PhDs with deep in vitro selection expertise.

$330B Market size
10 Key companies
6 Use cases

Key Companies

AbCellera Immunomedics MorphoSys Regeneron Ablynx Sanofi Harbour Biomed Ligand Pharmaceuticals Adimab Distributed Bio Sutro Biopharma

Use Cases

01

Antibody library licensing

02

Humanization and optimization services

03

Bispecific antibody co-development

04

ADC linker-payload partnerships

05

Fc engineering IP licensing

06

Single-cell discovery platform access

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started